| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP83 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | CD53 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | CCBE1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | TUFT1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | VHL | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | RLIM | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | MYBL1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | NLRP10 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | TCTA | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | PDXP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
